Glucuronic acid derivatives of opioid antagonists
US4774230A · kind A · utility
15Cited by
0References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 26, 1988 |
| Grant date | Sep 27, 1988 |
| Priority date | — |
| Expiry date | Mar 26, 2008 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07H17/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Intestine-specific delivery of an opioid antagonist can be accomplished without substantial central nervous system effects by administering the antagonist orally in the form of the glucuronide derivative.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.